PTC Therapeutics
A science-led, patient-centered biopharmaceutical company focused on discovering, developing and commercializing medicine for patients with rare disease.
Market cap
$4.0b
Enterprise value
$2.3b
Share price
$48.84 PTCT
Recent deals
Authorizing premium user...